Table 4.
Assay | Comments | References | |
---|---|---|---|
Phenotypic characterization Expression of embryonic and/or adult kidney markers |
Specificity of antibodies and probes should be shown using positive and negative controls |
27,29,30,31,34,37,41,42,43,44,45,46,47,48,49,50,56,57,59,63 |
|
Co-localization of multiple markers within the same cells and in neighboring segments should be shown |
|||
Quantification of kidney marker expression and absence of expression of nonkidney markers should be performed |
|||
Gene and protein expression levels should be interpreted cautiously in heterogeneous differentiated cell populations |
|||
Marker expression should be consistent with a specific cell identity |
|||
Kidney epithelial structures | Insufficient without accompanying marker analysis because PSCs are epithelial cells and are capable of differentiating into diverse epithelia |
27,30,31,36,42,48,59,63 | |
Ultrastructural analysis (presence of brush border) could provide more supportive evidence of kidney phenotype |
|||
Evidence of hollow lumens surrounded by polarized epithelia should be presented |
|||
Functional analysis In vitro |
Biochemical assays of epithelial cell function |
Epithelial functions should be compared with primary kidney cells as positive controls and nonkidney epithelial cells as negative controls |
59 |
Integration into embryonic kidney explant cultures |
Results should be compared with stochastically differentiated PSCs as negative controls and primary fetal kidney cells as positive controls |
27,28,29,30,37,41,44,48,57,59,63 | |
In vivo | Formation of glomeruli and nephron structures |
Should be accompanied by marker analysis, ideally showing nephron segments in serial sections |
31 |
Urine production | Requires PSC-derived kidney tissue to be vascularized |
Not shown | |
Functional rescue after kidney injury |
Requires strategy to deliver cells to the kidney effectively |
Not shown |